企業プロフィール
Exagen 株価・ニュース・カタリスト
- ティッカー:
- XGN
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
6.70 USD (+0.60%)
終値
最終更新: 2026年8月17日
116M USD
時価総額
株価変動の要因
As of Aug 17, 2026, XGN closed up 0.60% at $6.70. No new same-company headline was identified in the current news window.
企業概要
Autoimmune Diagnostics
Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management.
AVISE CTD
AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines multiple biomarkers into an integrated result intended to improve diagnostic confidence. Exagen operates a centralized clinical laboratory and markets its AVISE portfolio primarily to rheumatologists. Revenue is generated through reimbursed testing, supported by payer coverage and physician adoption.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。